CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 1,316 shares (to pay taxes)
- 4 Open-market sale Director sold 5,832 shares at $329.65 ($1,922,519)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 780 shares at $320.55 ($250,029)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP Glob. Mkt Acc & Cust Innov acquired 2,350 shares (grant or award)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 157 shares (to pay taxes)
- 4 Gift Director gave 850 shares (gift)
- 4 Open-market buy Director bought 30,000 shares at an average $317.36 ($9,520,800)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
Page 22 of 86 · 1,714 filings